Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines Gene
DSpace/Manakin Repository
Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines Gene
| Title: | Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines Gene |
| Author: |
Nalls, Michael A.; Akylbekova, Ermeg L.; Patterson, Nick; Mullikin, James; Hsueh, Wen-Chi; Cheng, Ching-Yu; Coresh, Josef; Boerwinkle, Eric; Li, Man; Waliszewska, Alicja; Neubauer, Julie; Li, Rongling; Leak, Tennille S.; Ekunwe, Lynette; Files, Joe C.; Hardy, Cheryl L.; Zmuda, Joseph M.; Taylor, Herman A.; Ziv, Elad; Harris, Tamara B.; Wilson, James G.; Reich, David Emil; Kao, W. H. Linda; Tandon, Arti
Note: Order does not necessarily reflect citation order of authors. |
| Citation: | Reich, David, Michael A. Nalls, W. H. Linda Kao, Ermeg L. Akylbekova, Arti Tandon, Nick Patterson, James Mullikin, et al. 2009. Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines Gene. PLoS Genetics 5(1): e1000360. |
| Full Text & Related Files: |
2628742.pdf (640.3Kb; PDF) 
|
| Abstract: | Persistently low white blood cell count (WBC) and neutrophil count is a well-described phenomenon in persons of African ancestry, whose etiology remains unknown. We recently used admixture mapping to identify an approximately 1-megabase region on chromosome 1, where ancestry status (African or European) almost entirely accounted for the difference in WBC between African Americans and European Americans. To identify the specific genetic change responsible for this association, we analyzed genotype and phenotype data from 6,005 African Americans from the Jackson Heart Study (JHS), the Health, Aging and Body Composition (Health ABC) Study, and the Atherosclerosis Risk in Communities (ARIC) Study. We demonstrate that the causal variant must be at least 91% different in frequency between West Africans and European Americans. An excellent candidate is the Duffy Null polymorphism (SNP rs2814778 at chromosome 1q23.2), which is the only polymorphism in the region known to be so differentiated in frequency and is already known to protect against Plasmodium vivax malaria. We confirm that rs2814778 is predictive of WBC and neutrophil count in African Americans above beyond the previously described admixture association (P = 3.8×10^−5), establishing a novel phenotype for this genetic variant. |
| Published Version: | doi:10.1371/journal.pgen.1000360 |
| Other Sources: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628742/pdf/ |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:4820837 |
| Downloads of this work: |
This item appears in the following Collection(s)
-
HMS Scholarly Articles [20072]
Contact administrator regarding this item (to report mistakes or request changes)
